PNPLA3 and hepatocellular carcinoma: Among patients with the PNPLA3 CC genotype, none developed HCC in 5 years, whereas HCC was observed in 2.1% of cases with PNPLA3 GG/GC after 5 years (p = 0.17, Figure 3A).